
Sign up to save your podcasts
Or


As synthetic biology continues to evolve, the ability to control engineered organisms is more important now than ever. In this episode, B.Next's Dr. Kevin O'Connell is joined by Gabriel Lopez, the Co-founder and CEO of Synvivia, a company focused on building protein switches to control the behavior of genetically engineered organisms. Learn more about these protein switches, their commercial applications, how they can enhance biosecurity, and more.
Learn more at synvivia.com
By IQT4.7
2121 ratings
As synthetic biology continues to evolve, the ability to control engineered organisms is more important now than ever. In this episode, B.Next's Dr. Kevin O'Connell is joined by Gabriel Lopez, the Co-founder and CEO of Synvivia, a company focused on building protein switches to control the behavior of genetically engineered organisms. Learn more about these protein switches, their commercial applications, how they can enhance biosecurity, and more.
Learn more at synvivia.com

14,333 Listeners

5,099 Listeners

1,955 Listeners

9,555 Listeners

603 Listeners

1,070 Listeners

2,353 Listeners

723 Listeners

112,451 Listeners

426 Listeners

5,567 Listeners

10,019 Listeners

693 Listeners

405 Listeners

463 Listeners